Results 121 to 130 of about 30,697 (246)

Ethical Considerations Regarding the Vaccination of Children—The Power Dynamics Between Doctors and Parents

open access: yesActa Paediatrica, Volume 115, Issue 11, Page 2414-2420, November 2026.
ABSTRACT While childhood vaccination programmes provide outstanding contributions to improving health, they can also pose challenges through the interactions between parents and healthcare. This paper focuses on the ethical dimensions of interactions between healthcare professionals and parents. Since the knowledge that professionals possess creates an
Mikael Sandlund   +2 more
wiley   +1 more source

Modelling Impact of Different Varicella Immunisation Strategies Upon Introduction in the Swedish National Programme

open access: yesActa Paediatrica, Volume 115, Issue 11, Page 2525-2532, November 2026.
ABSTRACT Aim Countries with varicella immunisation programmes have seen major reductions in disease burden. While two‐dose schedules are now universally adopted, dosing ages vary, and some countries initially include catch‐up vaccination of older children to speed impact. This modelling study assessed three two‐dose schedules in the Swedish setting (1)
Gianpaolo Scalia Tomba   +6 more
wiley   +1 more source

Akut rubeola hepatiti

open access: yes, 1998
Akut viral hepatit etyolojisinde, hepatit A, B, C, D ve E virüsleri majör etkenlerdir. Ancak sık görülmemekle beraber diğer virüs enfeksiyonlarının seyri sırasında da akut viral hepatit gelişebilmektedir.

core  

Rationale for Recommending Varicella Vaccination Into the Swedish National Immunisation Programme

open access: yesActa Paediatrica, Volume 115, Issue 11, Page 2460-2465, November 2026.
ABSTRACT Aim Under Swedish law, a vaccination may be included in the National Immunisation Programme (NIP) if it effectively prevents transmission in the population, is cost‐effective and aligns with ethical and humanitarian principles. The Public Health Agency of Sweden (PHAS) evaluated these criteria for introducing varicella vaccination. Methods The
Annika Ersson   +2 more
wiley   +1 more source

Health Economic Evaluation of Varicella Vaccination Within the Swedish National Vaccination Programme for Children

open access: yesActa Paediatrica, Volume 115, Issue 11, Page 2533-2544, November 2026.
ABSTRACT Aim To assess the cost‐effectiveness of including varicella vaccination in the Swedish national vaccination programme for children together with the added impact of catch‐up vaccination of susceptible older children. Methods An epidemiological transmission model was used to assess the cost‐effectiveness of a two‐dose national varicella ...
Frida Kasteng   +5 more
wiley   +1 more source

A Personalised Vaccination Program Based on Immune Reconstitution in Paediatric Cancer Survivors

open access: yesActa Paediatrica, Volume 115, Issue 11, Page 2603-2615, November 2026.
ABSTRACT Aims Paediatric cancer survivors often experience treatment‐induced immunosuppression, requiring post‐treatment revaccination. However, immune recovery timelines vary, and current revaccination guidelines, largely based on data of varied quality derived from studies on acute‐lymphoblastic‐leukaemia (ALL), may not be applicable across all ...
Menucha Jurkowicz   +17 more
wiley   +1 more source

Prevalencia de anticuerpos protectores frente a sarampión, rubeola y parotiditis en la población infantil del área sanitaria de León

open access: yes, 1990
La vacuna triple vírica (sarampión-rubeola-parotiditis), se usa en España desde 1981. Las monovalentes (antisarampión y antirubeola) desde finales de la década de los setenta. Se pretende conocer la eficacia de estas vacunaciones.
Suárez Estrada, Juan
core  

Socioeconomic Risk Factors for Incomplete Vaccination in Swedish Two‐Year‐Olds—A Nationwide, Population‐Based Cohort Study

open access: yesActa Paediatrica, Volume 115, Issue 11, Page 2555-2565, November 2026.
ABSTRACT Aim To analyse the association between specific socioeconomic measures and the risk of incomplete vaccination for diphtheria‐tetanus‐pertussis (DTP) and measles‐containing vaccine (MCV) in Swedish two‐year‐olds. Methods This nationwide, population‐based cohort study included 227 457 children born in Sweden during 2014–2015.
Cecilia Chrapkowska Almqvist   +5 more
wiley   +1 more source

Update on Selected Adverse Events of Concern Following Immunization With Acellular Pertussis Vaccines, a Narrative Review

open access: yesActa Paediatrica, Volume 115, Issue 11, Page 2370-2379, November 2026.
ABSTRACT Aim To provide an update paper on evidence of adverse events of concern following immunization (AEFI) with pertussis vaccines, focusing primarily on acellular (aP) vaccines. Methods Evidence was synthesised from epidemiological studies, systematic reviews over recent decades, expert interpretations in reviews from relevant research teams and ...
Lennart Nilsson, Jann Storsaeter
wiley   +1 more source

Estudio de seroprevalencia de la rubéola en las mujeres en edad fértil de Aragón (2003-2007) Seroepidemiologic study of rubella in childbearing women in Aragon, Spain (2003-2007)

open access: yesGaceta Sanitaria, 2011
Objetivos: Cuantificar la población susceptible a la rubéola en Aragón, caracterizarla según las variables sociodemográficas y evaluar el cumplimiento del límite establecido por la Organización Mundial de la Salud (OMS) del 5%.
Rogelio Hernández Díaz   +4 more
doaj  

Home - About - Disclaimer - Privacy